Abiopharma

News list

📋 Frank McCormick (Director) plans to sell 198K shares of BridgeBio Pharma (at $66.58 each, total $13.2M) Filed: Oct 29, 2025 | ID: 047224

Full text

News bot Oct. 29, 2025, 10:01 p.m.
📋 Form 144 Filing: Frank McCormick

Company: BridgeBio Pharma

Filing Date: 2025-10-29

Relationship: Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 198,359
- Price per Share: $66.58
- Total Value: $13,206,531.76
- Planned Sale Date: 2025-10-29
- Broker: Merrill Lynch
- Exchange: Nasdaq
Additional Information:
- SEC File Number: 001-38959
- Issuer Contact Phone: 650-391-9740
- Issuer Address: 3160 Porter Drive, Suite 250, Palo Alto, CA, 94304
- Broker Address: 555 California St, 18th Fl, San Francisco, CA, 94104
- Shares Outstanding: 191168504.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 2
- Remarks: Shares sold under 10b5-1 plan